|
|
Title | Creator | Date |
151 |
|
Pediatric Optic Neuritis Prospective Outcomes Study | Stacy L. Pineles, MD; Grant T. Liu, MD; Amy T. Waldman, MD; Elizabeth Lazar, MS, MPH; Mark J. Kupersmith, MD; Michael X. Repka, MD, MBA; for the Pediatric Eye Disease Investigator Groupand the Neuro-Ophthalmology Research Disease Investigator Consortium | 2016-06 |
152 |
|
Preferential Ganglion Cell Loss in the Nasal Hemiretina in Patients With Pituitary Tumor | Ah Reum Jeong, MD; Eun-Young Kim, MD, PhD; Na Rae Kim, MD, PhD | 2016-06 |
153 |
|
Literature Commentary | Mark L. Moster, MD; Marc J. Dinkin, MD; Deborah I. Friedman, MD, MPH | 2022-09 |
154 |
|
The Torsional Component of Horizontal Congenital Nystagmus | Averbuch-Heller, L; Dell'Osso, L; Leigh, RJ; Jacobs, JB; Stahl, JS | |
155 |
|
Aspirin Reduces the Incidence of Second Eye NAION | Kupersmith, MJ; Frohman, L; Sanderson, M; Jacobs, J; Hirschfeld, J; Ku, C; Warren, FA | |
156 |
|
Resolution of Homonymous Visual Field Loss Documented with Functional Magnetic Resonance and Diffusion Tensor Imaging | Yoshida, M; Ida, M; Nguyen, TH; Iba-Zizen, MT; Bellinger, L; Stievenart, JL; Nagao, T; Kikuchi, S; Hara, T; Shiba, T; Kitahara, K; Cabanis, EA | |
157 |
|
Treatment Response in Pediatric Patients With Pseudotumor Cerebri Syndrome | Eliel Tovia, MD; Shimon Reif, MD; Asaf Oren, MD; Alexis Mitelpunkt, MD; Aviva Fattal-Valevski, MD, MHA | 2017-12 |
158 |
|
Visual Outcomes and Clinical Manifestations of Pediatric Optic Neuritis in Indian Population: An Institutional Study | Selvakumar Ambika, DO, DNB; Krishnakumar Padmalakshmi, DO, DNB; Viswanathan Venkatraman, MD; Olma V. Noronha, DNB | 2018-12 |
159 |
|
Magnetic Resonance Imaging of the Brain in Nonarteritic Ischemic Optic Neuropathy | Arnold, AC; Hepler, RS; Hamilton, DR; Lufkin, RB | |
160 |
|
Delayed radiation injury to the retrobulbar optic nerves and chiasm. clinical syndrome and treatment with hyperbaric oxygen and corticosteroids. | | |
161 |
|
Editors Corner | | 1994-09 |
162 |
|
Effect of visual blur on constrast sensitivity. | | |
163 |
|
Management of nontraumatic vascular shunts involving the cavernous sinus. | | |
164 |
|
The nasal junction scotoma in giant aneurysms. | | |
165 |
|
Optic nerve sheath decompression. | | |
166 |
|
Plasmacytoma of the orbit. | | |
167 |
|
Treatment of optic neuritis with intravenous megadose corticosteroids. A consecutive series. | | |
168 |
|
The Impact of COVID-19 on Neuro-Ophthalmology Office Visits and Adoption of Telemedicine Services | Heather E. Moss; Melissa W. Ko; Devin D. Mackay; Divya Chauhan; Karen G. Gutierrez; Natacha C. Villegas; Kevin E. Lai | 2021-09 |
169 |
|
Neuro-Ophthalmic Phenotype of OPA3 | R. Huna-Baron; G. Yahalom; Y. Anikster; B. Ben Zeev; C. Hoffmann; S. Hassin-Baer | 2022-03 |
170 |
|
Should Patients With Acute Central Retinal Artery Occlusion Be Treated With Intra-arterial t-PA? | Robert A. Egan; Renee Van Stavern | |
171 |
|
Visual field examination during transient migrainous visual loss. | R. Ebner | |
172 |
|
Cyclotorsion Measurement on Scanning Laser Ophthalmoscopy Imaging Compared With Fundus Photography in Patients With Fourth Nerve Palsy and Healthy Controls: CySLO-IV Study | Madeleine S. Kanku, MD; Silvano Sele, Msc; Ulrike Held, PhD; Gregor P. Jaggi, MD; Klara Landau, MD; Ghislaine L. Traber, MD | 2021-12 |
173 |
|
Visually Induced Reactivity in Posterior Cerebral Artery Blood Flow | Spelsberg, B; Bohning, A; Kompf, D; Kessler, C | |
174 |
|
Neuro-Ophthalmic Complications in Patients Treated With CTLA-4 and PD-1/PD-L1 Checkpoint Blockade | Michel M. Sun, MD, PhD; Nicolas Seleme, MD; John J. Chen, MD, PhD; Anastasia Zekeridou, MD, PhD; Elia Sechi, MD; Ryan D. Walsh, MD; Johanna D. Beebe, MD; Osama Sabbagh, MD; Luis J. Mejico, MD; Sean Gratton, MD; Philip M. Skidd, MD; David A. Bellows, MD; Julie Falardeau, MD; Clare L. Fraser, MD; Ceci... | 2021-12 |
175 |
|
Bitemporal Visual Field Defects in Ethambutol-Induced Optic Neuropathy | Kho, Richard C; Al-Obailan, Majed; Arnold, Anthony C | |